VRTX Earnings Vertex Pharmaceuticals
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 4.02 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | 15.32 | 2026-02-13 | 10-K |
| Q3 2025 | 2025-09-30 | 10.68 | 2025-11-04 | 10-Q |
| Q2 2025 | 2025-06-30 | 6.48 | 2025-08-05 | 10-Q |
| Q1 2026 | 2025-03-31 | 2.49 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | -2.08 | 2026-02-13 | 10-K |
| Q3 2025 | 2024-09-30 | -5.61 | 2025-11-04 | 10-Q |
| Q2 2025 | 2024-06-30 | -9.66 | 2025-08-05 | 10-Q |
| Q1 2025 | 2024-03-31 | 4.21 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | 13.89 | 2026-02-13 | 10-K |
| Q3 2024 | 2023-09-30 | 10.18 | 2024-11-05 | 10-Q |
| Q2 2024 | 2023-06-30 | 6.21 | 2024-08-02 | 10-Q |
| Q1 2024 | 2023-03-31 | 2.69 | 2024-05-07 | 10-Q |
| FY 2024 | 2022-12-31 | 12.82 | 2025-02-13 | 10-K |
| Q3 2023 | 2022-09-30 | 9.68 | 2023-11-07 | 10-Q |
| Q2 2023 | 2022-06-30 | 6.09 | 2023-08-02 | 10-Q |
| Q1 2023 | 2022-03-31 | 2.96 | 2023-05-02 | 10-Q |
| FY 2023 | 2021-12-31 | 9.01 | 2024-02-15 | 10-K |
| Q3 2022 | 2021-09-30 | 6.03 | 2022-10-28 | 10-Q |
| Q2 2022 | 2021-06-30 | 2.75 | 2022-08-05 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.